Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Market Vectors Biotech ETF

+ Add to Watchlist

BBH:US

131.9400 USD 2.5800 1.99%

As of 20:04:02 ET on 03/27/2015.

Snapshot for Market Vectors Biotech ETF (BBH)

Open: 129.8700 High - Low: 132.7300 - 129.8300 Primary Exchange: NYSE Arca
Volume: 108,433 52-Week Range: 80.0500 - 140.7200 Beta vs MVBBHTR: 1.0004

ETF Chart for BBH

No chart data available.
  • BBH:US 131.9400
  • 1D
  • 1M
  • 1Y
129.3600
Interactive BBH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BBH

Market Vectors Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the US Listed Biotech 25 Index.

Inception Date: 2011-12-21 Telephone: 1-212-293-2000
Managers: PETER LIAO / GEORGE CAO
Web Site: www.vaneck.com

Fundamentals for BBH

NAV (on 2015-03-27) 131.9326
Assets (M) (on 2015-03-27) 797.7308
Shares out (M) 6.05
Market Cap (M) 797.78
% Premium 0.01
Average 52-Week % Premium -0.0055
Fund Leveraged N

Dividends for BBH

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2013-12-23) 0.0030
Dividend Yield (ttm) -%

Performance for BBH

1-Month +3.09% 1-Year +45.45%
3-Month +13.16% 3-Year +44.70%
Year To Date +14.35% 5-Year -
Expense Ratio 0.35

Top Fund Holdings for BBH

Filing Date: 03/26/2015
Name Position Value % of Total
Gilead Sciences Inc 1,100,122 111,194,831 14.191%
Amgen Inc 591,660 94,991,013 12.123%
Celgene Corp 730,967 86,005,577 10.976%
Biogen Inc 161,259 69,168,823 8.827%
Regeneron Pharmaceuticals Inc 91,858 41,186,831 5.256%
BioMarin Pharmaceutical Inc 306,670 35,435,719 4.522%
Alexion Pharmaceuticals Inc 196,289 34,554,716 4.410%
Illumina Inc 184,500 34,016,265 4.341%
Vertex Pharmaceuticals Inc 286,190 33,655,944 4.295%
Medivation Inc 248,588 31,913,727 4.073%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil